miR-511 Deficiency Protects Mice from Experimental Colitis by Reducing TLR3 and TLR4 Responses via WD Repeat and FYVE-Domain-Containing Protein 1.
Adaptor Proteins, Signal Transducing
/ metabolism
Animals
Colitis
/ chemically induced
Colon
/ pathology
Dextran Sulfate
Female
Gene Expression Regulation
Inflammation
/ genetics
Lipopolysaccharides
Macrophages
/ metabolism
Male
Mice, Inbred C57BL
MicroRNAs
/ genetics
Monocytes
/ metabolism
Toll-Like Receptor 3
/ metabolism
Toll-Like Receptor 4
/ metabolism
TLRs
intestinal inflammation
miR-511
mouse
wdfy1
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
25 12 2021
25 12 2021
Historique:
received:
17
11
2021
revised:
17
12
2021
accepted:
21
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
4
3
2022
Statut:
epublish
Résumé
Antimicrobial responses play an important role in maintaining intestinal heath. Recently we reported that miR-511 may regulate TLR4 responses leading to enhanced intestinal inflammation. However, the exact mechanism remained unclear. In this study we investigated the effect of miR-511 deficiency on anti-microbial responses and DSS-induced intestinal inflammation. miR-511-deficient mice were protected from DSS-induced colitis as shown by significantly lower disease activity index, weight loss and histology scores in the miR-511-deficient group. Furthermore, reduced inflammatory cytokine responses were observed in colons of miR-511 deficient mice. In vitro studies with bone marrow-derived M2 macrophages showed reduced TLR3 and TLR4 responses in miR-511-deficient macrophages compared to WT macrophages. Subsequent RNA sequencing revealed Wdfy1 as the potential miR-511 target. WDFY1 deficiency is related to impaired TLR3/TLR4 immune responses and the expression was downregulated in miR-511-deficient macrophages and colons. Together, this study shows that miR-511 is involved in the regulation of intestinal inflammation through downstream regulation of TLR3 and TLR4 responses via Wdfy1.
Identifiants
pubmed: 35011620
pii: cells11010058
doi: 10.3390/cells11010058
pmc: PMC8750561
pii:
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
Lipopolysaccharides
0
MicroRNAs
0
Mirn511 microRNA, mouse
0
Toll-Like Receptor 3
0
Toll-Like Receptor 4
0
Wdfy1 protein, mouse
0
Dextran Sulfate
9042-14-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Dutch Ministry of Economic Affairs, LSH-TKI, Health Holland, MNEON
ID : Project number LSHM17028
Références
J Alzheimers Dis. 2011;24(4):721-38
pubmed: 21321390
Lab Invest. 1993 Aug;69(2):238-49
pubmed: 8350599
BMC Gastroenterol. 2012 Apr 16;12:33
pubmed: 22507600
Int J Oncol. 2018 Dec;53(6):2715-2726
pubmed: 30272349
Inflamm Bowel Dis. 2010 Sep;16(9):1583-97
pubmed: 20803699
Nutrients. 2021 Apr 15;13(4):
pubmed: 33920960
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Mucosal Immunol. 2016 Jul;9(4):960-73
pubmed: 26530135
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Dig Dis Sci. 2002 Sep;47(9):2056-63
pubmed: 12353855
J Pathol. 2020 Apr;250(5):656-666
pubmed: 32086805
Arch Immunol Ther Exp (Warsz). 2020 Apr 1;68(2):10
pubmed: 32239308
Nucleic Acids Res. 2009 Apr;37(6):e45
pubmed: 19237396
Nucleic Acids Res. 2012 Sep 1;40(17):e133
pubmed: 22638577
J Biol Chem. 2016 Aug 19;291(34):17897-906
pubmed: 27334923
Oncol Rep. 2014 Mar;31(3):1473-9
pubmed: 24402374
Mol Neurobiol. 2019 May;56(5):3132-3144
pubmed: 30097850
Crit Rev Oncol Hematol. 2016 Jan;97:118-30
pubmed: 26318097
Int Immunol. 2017 Apr 1;29(4):157-163
pubmed: 28383678
Korean J Physiol Pharmacol. 2014 Aug;18(4):279-88
pubmed: 25177159
Circ Res. 2016 Feb 19;118(4):703-20
pubmed: 26892968
EMBO Rep. 2015 Apr;16(4):447-55
pubmed: 25736436
Mucosal Immunol. 2013 May;6(3):498-510
pubmed: 22990622
Annu Rev Immunol. 2008;26:421-52
pubmed: 18303997
Cancer Biomark. 2019;26(3):343-351
pubmed: 31524148
Nat Commun. 2019 Jul 19;10(1):3229
pubmed: 31324779
Oncol Res. 2018 Oct 17;26(9):1355-1363
pubmed: 29321086
Nat Genet. 2005 Jul;37(7):766-70
pubmed: 15965474
Cell Rep. 2012 Feb 23;1(2):141-54
pubmed: 22832163
Nutr Res. 2015 Dec;35(12):1106-12
pubmed: 26500083
Allergol Immunopathol (Madr). 2018 Sep - Oct;46(5):503-507
pubmed: 29398117
Eur J Immunol. 2017 Dec;47(12):2080-2089
pubmed: 28776644
Autophagy. 2013 May;9(5):789-90
pubmed: 23388383
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
J Allergy Clin Immunol. 2018 Jan;141(1):350-364.e8
pubmed: 28629744
Trends Immunol. 2014 Jun;35(6):270-7
pubmed: 24794393
J Cell Sci. 2001 Nov;114(Pt 22):3991-4000
pubmed: 11739631
J Clin Gastroenterol. 2013 Oct;47(9):773-80
pubmed: 23470644
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Cell Mol Immunol. 2020 Sep;17(9):1014-1016
pubmed: 32398807
Arthritis Res Ther. 2005;7(2):R370-9
pubmed: 15743485
J Biol Chem. 2011 Jul 29;286(30):26487-95
pubmed: 21646346
Sci Rep. 2016 Mar 30;6:23588
pubmed: 27026195
Nat Methods. 2015 Feb;12(2):115-21
pubmed: 25633503
J Neuroimmunol. 2018 Mar 15;316:65-73
pubmed: 29305044
J Exp Med. 2003 May 5;197(9):1107-17
pubmed: 12719479
Adv Drug Deliv Rev. 2007 Sep 30;59(11):1073-83
pubmed: 17825455
EMBO Mol Med. 2015 May 20;7(8):1004-17
pubmed: 25995337